trustme.bro/r/…
✓ checked
trust me, bro:
here is the receipt.
the claim

Antibodies are not used as treatments for infectious diseases

the verdict
REFUTED
the evidence says no
Recorded sources
0 sources for · 4 against

Counts group repeated records of the same source within each side. They do not measure evidence strength or source independence.

Antibodies are widely used and studied as effective treatments and immunotherapies for various infectious diseases, directly contradicting the claim.

The analysis

The claim states that antibodies are not used as treatments for infectious diseases. Multiple retrieved papers explicitly discuss the use of therapeutic antibodies and monoclonal antibodies for treating infectious conditions (such as bacterial infections, fungal diseases, and viral infections). Therefore, the claim is clearly refuted by the literature.

Evidence against · 4
Development of therapeutic antibodies for the treatment of diseases
Recorded source metadata

Ruei‐Min Lu, Yu‐Chyi Hwang, I-Ju Liu, Chi‐Chiu Lee, Han-Zen Tsai, Hsin‐Jung Li, Han‐Chung Wu. Development of therapeutic antibodies for the treatment of diseases. 2020. https://doi.org/10.1186/s12929-019-0592-z

This review highlights that therapeutic antibodies are approved for treating various human diseases, including infectious diseases.

See more details
More against · 3
Unique antibodies across the animal kingdom (birds, camelids, and sharks): therapeutic potential against human respiratory viral infections.
Recorded source metadata

Basabrain AA, Alandijany TA. Unique antibodies across the animal kingdom (birds, camelids, and sharks): therapeutic potential against human respiratory viral infections.. 2025. https://doi.org/10.3389/fimmu.2025.1723343

This paper notes that antibodies represent indispensable tools against infectious diseases, with widespread application in therapeutic settings.

Combination therapy for fungal diseases: the role of immunotherapy in the present and the future.
Recorded source metadata

Seldeslachts L, Feys S, van de Veerdonk FL, Wauters J. Combination therapy for fungal diseases: the role of immunotherapy in the present and the future.. 2026. https://doi.org/10.1097/qco.0000000000001220

This review lists monoclonal antibodies as part of the expanding range of adjunctive immunotherapies used in treating infectious diseases such as fungal infections.

Targeting a conserved flagellin D1 epitope with 16G10 confers cross-serotype protection in murine <i>Pseudomonas aeruginosa</i> infection models.
Recorded source metadata

Wang Y, Wang Y, Zhu Z, Wang Q, Liu X, Cai Q, Zhang Y, Li Y, Zhao H, Cheng X, Gu J, Zou Q, Jiang J. Targeting a conserved flagellin D1 epitope with 16G10 confers cross-serotype protection in murine <i>Pseudomonas aeruginosa</i> infection models.. 2026. https://doi.org/10.1080/21645515.2026.2689214

This study demonstrates that monoclonal antibodies can be used successfully as a post-infection immunotherapy to improve survival in bacterial infection models.

The paper trail · every fact has a biography
first checked02 Aug 2026
judged → REFUTED · 2102 Aug 2026
Anyone with this link can read the claim and its public receipt, including any personal information in that text. Open permanent receipt.
Check your own claim
Challenge the receipt
Requests are recorded for review. This does not start an automatic check or guarantee a response time.
trust me, bro: win the argument, pass the class, survive peer review.

Citation formatting by citeproc-js (Frank Bennett) and the Citation Style Language project. Source and licenses.

This receipt is an automated verdict against our published method · not an opinion about any author or publication.
Terms · Privacy · How verdicts work · Dispute this receipt